CDC Report Warns of Serious Ocular Complications With Monkeypox
Prompt initiation of systemic antiviral therapy in addition to topical trifluridine should be considered in patients with ocular manifestations of monkeypox.
Viral Infections
Bivalent COVID-19 Vaccines Authorized for Use as Boosters in Children
The bivalent Moderna and Pfizer-BioNTech COVID-19 Vaccines are authorized as a single booster dose at least 2 months after the primary or booster vaccination.
September 2022 Recap: Drug Pipeline Updates
The table provided is a review of notable updates that occurred in September 2022 for investigational products in development.
CDC Will Stop Issuing Daily Updates of COVID-19 Cases, Deaths
Move is in line with efforts to wind down other COVID-19-related tools on the CDC website
Real-World Data Provide Insight Into Oral COVID-19 Antiviral Molnupiravir
Molnupiravir is a nucleoside analogue that inhibits SARS-CoV-2 replication by viral mutagenesis.
COVID-19 Boosters Could Save 90,000 Lives This Winter
Updated booster doses could also prevent more than 936,000 hospitalizations and save $56 billion in six months
CDC Warns of Possible Severe Flu Season Ahead
Making matters worse, only 49 percent of Americans plan to get a flu shot during the 2022-2023 flu season
New Trogarzo Administration Method Cuts Maintenance Dose Time for HIV Patients
The approval was based on data from the phase 3 TMB-302 trial that evaluated Trogarzo 800mg administered via IV push once every 2 weeks.
New-Onset A-Fib Profiled in Patients Hospitalized With COVID-19
New-onset atrial fibrillation identified in about 1 in 20 patients hospitalized with COVID-19
Presence of Particulate Prompts Recall of Acyclovir Intravenous Product
The administration of recalled product may lead to inflammation, allergic reactions, or circulatory system complications.
